Food Effect in Healthy Participants Clinical Trial
Official title:
A Phase I, Single-center, Randomized, Open-label, 2-cycle,2-period Crossover Study to Evaluate the Food Effect on the Pharmacokinetics of JAB-21822 in Healthy Subjects
The primary objective of this study is to determine the effect of food in healthy participants on the bioavailability of JAB-21822 following single dose administration with and without a meal
This is an open-label,randomized, 2-cycle,2-period crossover,food effect study. On Day 1 of each period, subjects will receive a single oral dose of JAB-21822 administered either under fasting conditions or following a standardized high-fat/high-calorie meal. PK sampling for JAB-21822 will be collected predose and postdose. There will be a washout period between doses. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT06012721 -
Effect of Food on the Pharmacokinetics of ORIC-114
|
Phase 1 | |
| Completed |
NCT03996226 -
A Food-Effect Study of E7386 in Healthy Participants
|
Phase 1 |